APA

Mayer E. A., Berman S., Derbyshire S. W. G., Suyenobu B., Chang L., Fitzgerald L., Mandelkern M., Hamm L., Vogt B. & Naliboff B. D. (20030131). The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. : Alimentary pharmacology & therapeutics.

Chicago

Mayer E A, Berman S, Derbyshire S W G, Suyenobu B, Chang L, Fitzgerald L, Mandelkern M, Hamm L, Vogt B and Naliboff B D. 20030131. The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. : Alimentary pharmacology & therapeutics.

Harvard

Mayer E. A., Berman S., Derbyshire S. W. G., Suyenobu B., Chang L., Fitzgerald L., Mandelkern M., Hamm L., Vogt B. and Naliboff B. D. (20030131). The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. : Alimentary pharmacology & therapeutics.

MLA

Mayer E A, Berman S, Derbyshire S W G, Suyenobu B, Chang L, Fitzgerald L, Mandelkern M, Hamm L, Vogt B and Naliboff B D. The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. : Alimentary pharmacology & therapeutics. 20030131.